Allozymes
Allozymes uses proprietary ultra-high-throughput microfluidics to screen 20 M enzyme variants daily. This deep enzyme database accelerates biosolutions across pharmaceuticals, chemicals, and personal care—reducing waste and boosting sustainability.
Founders
Peyman Salehian
CEO
Dr. Peyman is a scientist-entrepreneur with extensive experience in transferring technologies from the lab to the market. He completed a PhD at the National University of Singapore, during which he led industrial-academic collaborations focusing on bioprocesses and process scale-up.
Akbar Vahidi
CTO
Dr. Akbar is a scientist-entrepreneur and received his PhD in Biocatalysis from the National University of Singapore. He invented Allozymes’ technology when he was working as a lead research fellow at NUS. Akbar has more than 10 years of experience in various aspects of enzyme technology and has delivered several industrial projects for various sectors such as pharma, food, and feed.